Literature DB >> 22843493

Characteristics of hypertension in the Chinese population.

Ji-Guang Wang1, Yan Li.   

Abstract

In China, the prevalence of hypertension is currently 18.8 %, and a major risk factor for hypertension is unbalanced dietary sodium and potassium intakes. High dietary sodium intake may change the circadian rhythm of 24-h blood pressure, which is characterized by a higher nighttime blood pressure. The prevalence of isolated nighttime hypertension, defined as a nighttime blood pressure of at least 120 mm Hg systolic or 70 mm Hg diastolic and a daytime systolic/diastolic blood pressure less than 135/85 mm Hg, is higher in Chinese than in Europeans. The complications of hypertension are also different across ethnicities, being mainly stroke instead of myocardial infarction in Chinese. Lowering of blood pressure provides more protection against stroke than against myocardial infarction, and calcium channel blockers provide more protection against stroke than do other classes of antihypertensive drugs. Current Chinese hypertension guidelines recommend calcium channel blockers as the most suitable class of drugs of the five classes of antihypertensive drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843493     DOI: 10.1007/s11906-012-0288-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  30 in total

1.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  Utilization of genetic information for the dissection of complex diseases or traits.

Authors:  Ji-Guang Wang; Ming Liu
Journal:  Hypertens Res       Date:  2011-10-20       Impact factor: 3.872

Review 3.  Blood pressure control--special role of the kidneys and body fluids.

Authors:  A C Guyton
Journal:  Science       Date:  1991-06-28       Impact factor: 47.728

4.  Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview.

Authors:  Ji-Guang Wang; Yan Li; Stanley S Franklin; Michel Safar
Journal:  Hypertension       Date:  2007-05-14       Impact factor: 10.190

5.  Shanghai trial of nifedipine in the elderly (STONE).

Authors:  L Gong; W Zhang; Y Zhu; J Zhu; D Kong; V Pagé; P Ghadirian; J LeLorier; P Hamet
Journal:  J Hypertens       Date:  1996-10       Impact factor: 4.844

6.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

Authors:  L Liu; J G Wang; L Gong; G Liu; J A Staessen
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

7.  Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.

Authors:  L V Franse; M Pahor; M Di Bari; G W Somes; W C Cushman; W B Applegate
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

8.  Blood pressure and urinary sodium excretion in relation to the A-1984G adrenomedullin polymorphism in a Chinese population.

Authors:  Y Li; J A Staessen; L-H Li; P-J Gao; L Thijs; E Brand; S M Brand-Herrmann; D-L Zhu; J-G Wang
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

9.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study.

Authors:  José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen
Journal:  Lancet       Date:  2007-10-06       Impact factor: 79.321

10.  Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers.

Authors:  K Kario; T Matsuo; H Kobayashi; M Imiya; M Matsuo; K Shimada
Journal:  Hypertension       Date:  1996-01       Impact factor: 10.190

View more
  13 in total

1.  Dietary Approach to Stop Hypertension with Sodium Reduction for Chinese Canadians (DASHNa-CC): A Pilot Randomized Controlled Trial.

Authors:  P Zou; C-L Dennis; R Lee; M Parry
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

2.  Clinical risk model assessment for cardiovascular autonomic dysfunction in the general Chinese population.

Authors:  L Zhang; Z-H Tang; F Zeng; Z Li; L Zhou; Y Li
Journal:  J Endocrinol Invest       Date:  2015-01-03       Impact factor: 4.256

3.  The 2014 hypertension guidelines: implications for patients and practitioners in Asia.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Paolo Verdecchia
Journal:  Heart Asia       Date:  2015-11-24

Review 4.  Diet and Blood Pressure Control in Chinese Canadians: Cultural Considerations.

Authors:  Ping Zou
Journal:  J Immigr Minor Health       Date:  2017-04

5.  Chinese herbal medicine qi ju di huang wan for the treatment of essential hypertension: a systematic review of randomized controlled trials.

Authors:  Jie Wang; Xingjiang Xiong; Guoyan Yang; Yuqing Zhang; Yongmei Liu; Yun Zhang; Zhenpeng Zhang; Jun Li; Xiaochen Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-25       Impact factor: 2.629

6.  Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial.

Authors:  Juan Li; Hui Zheng; Ling Zhao; Ying Li; Yan Zhang; Xiao-rong Chang; Rui-hui Wang; Jing Shi; Jin Cui; Yin-lan Huang; Xiang Li; Jie Chen; De-hua Li; Fan-rong Liang
Journal:  Trials       Date:  2013-11-11       Impact factor: 2.279

7.  Hypertension Prevalence, Health Service Utilization, and Participant Satisfaction: Findings From a Pilot Randomized Controlled Trial in Aged Chinese Canadians.

Authors:  Ping Zou; Cindy-Lee Dennis; Ruth Lee; Monica Parry
Journal:  Inquiry       Date:  2017-01-01       Impact factor: 1.730

8.  The effect of body mass index and physical activity on hypertension among Chinese middle-aged and older population.

Authors:  Wenzhen Li; Dongming Wang; Chunmei Wu; Oumin Shi; Yanfeng Zhou; Zuxun Lu
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

9.  A Smartphone App (mDASHNa-CC) to Support Healthy Diet and Hypertension Control for Chinese Canadian Seniors: Protocol for Design, Usability and Feasibility Testing.

Authors:  Ping Zou; Jennifer Stinson; Monica Parry; Cindy-Lee Dennis; Yeqin Yang; Zhongqiu Lu
Journal:  JMIR Res Protoc       Date:  2020-04-02

10.  Twenty-year time trends in hypertension prevalence in Yi people of China: three successive cross-sectional studies, 1996-2015.

Authors:  Jia Zhang; Shaoping Wan; Biao Zhang; Fen Dong; Li Pan; Wuli Yihuo; Haiying Gong; Fang Yang; Guodong Xu; Zheng Li; Guoju Li; Yanlong Li; Xiaoyang Wang; Guangliang Shan
Journal:  BMJ Open       Date:  2018-10-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.